# At-Home Diagnostic Systems GenHome is a CES 2024 Innovation Awards Honoree By Laura McQuarrie | Published 2023-11-22 | Tech Source: Trend Hunter, https://www.trendhunter.com/trends/genhome References: [ces.tech](https://www.ces.tech/innovation-awards/honorees/2024/honorees/g/genhome.aspx)  GenHome, the in vitro diagnostic platform based on molecular diagnosis for self-examination, is a CES 2024 Innovation Awards Honoree in the Digital Health category that introduces the future of [at-home diagnostics](https://www.trendhunter.com/trends/dengue-home-test-kit). This hybrid diagnostic system combines [isothermal amplification and LFA](https://www.trendhunter.com/trends/molecular-testing) (lateral flow assay) to ensure accuracy and 100 times the precision of conventional rapid tests. This everyday wellness device is poised to usher in a new era of affordable healthcare by having users collect oral or nasal swabs, and place them within a secure unit for testing. After some time has passed, the device reveals the results, indicating whether a user has tested positive or negative (or if the results were invalid) for [COVID-19, influenza and RSV](https://www.trendhunter.com/trends/respiratory-test), all at once. ## Trend Insights (Trend Hunter) - Score: 5.7/10 - Popularity: 69% | Activity: 84% | Freshness: 19% - Audience gender: 50% men, 50% women - Primary generations: Millennial - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Tech](https://www.trendhunter.com/tech) > [Gadgets](https://www.trendhunter.com/gadgets) ## Key Themes ### Key Themes Behind This Trend - **At-home Diagnostic Systems:** The rise of at-home diagnostic systems allows individuals to take charge of their health by conducting tests in the comfort of their own homes. - **Molecular Diagnosis:** The implementation of molecular diagnosis in at-home diagnostic systems revolutionizes the accuracy and precision of rapid tests, providing users with reliable results. - **Hybrid Diagnostic Systems:** The integration of isothermal amplification and lateral flow assay (LFA) in a hybrid diagnostic system offers an innovative approach to self-examination, ensuring accurate and efficient testing. ### Where This Applies - **Digital Health:** The digital health industry is poised to benefit from the development of at-home diagnostic systems, which streamline the process of obtaining medical insights. - **Biotechnology:** The biotechnology industry can seize the opportunity presented by molecular diagnosis, by leveraging this technology to create advanced diagnostic tools and improve healthcare outcomes. - **Consumer Electronics:** The consumer electronics industry has the potential to disrupt the healthcare market by producing innovative devices, like GenHome, that bring affordable and accessible diagnostics to the masses. ## Related on Trend Hunter - [Automated Molecular Diagnostic Systems](https://www.trendhunter.com/trends/genhome-array.md) - [Cutting-Edge Diagnostic Tools](https://www.trendhunter.com/trends/cuttingedge-diagnostic-tool.md) - [Molecular Diagnostic Tools](https://www.trendhunter.com/trends/covidflu-test.md) - [Three-in-One At-Home Health Tests](https://www.trendhunter.com/trends/indicaid-covid19flu-ab-home-test.md) - [Instant At-Home Monitoring Systems](https://www.trendhunter.com/trends/hormometer.md) - [Expanded Diagnostic Platforms](https://www.trendhunter.com/trends/diagnostic-platforms.md) - [Virtual Health Test Platforms](https://www.trendhunter.com/trends/cue-health.md) - [Award-Winning Blood-Based Diagnostic Platforms](https://www.trendhunter.com/trends/bloodbased-diagnostic-platform.md) - [At-Home Diagnostics Startups](https://www.trendhunter.com/trends/truepill.md)